[[bpstrwcotob]]
How Coating Selection Shapes Pharmaceutical Facility Readiness
Early coating and flooring decisions can help pharmaceutical project teams avoid construction delays, support regulatory requirements, and create facilities that are easier to maintain and operate over the long term
Best Practices in Building Flexible and Affordable Labs
Identify ways to reduce costs, improve flexibility, and shorten delivery times on lab renovations and new builds
An Architect’s Role in Brownfield Site Selection: What You Should Know
Involving architects early in brownfield site selection helps identify structural, infrastructure, compliance, and operational challenges before purchase, reducing risk, avoiding costly redesigns, and ensuring the facility can support current and future cGMP operations
GMP vs. Non-GMP Zones: Managing Personnel Flow
By designing rigorous airlocks and unidirectional gowning rooms, architects can enforce strict personnel flow, bridging the gap between uncontrolled office environments and classified GMP manufacturing zones.
Project Profile: The Ritedose Corporation
Ritedose Corporation is investing over $17 million to triple its cGMP lab footprint in Columbia, SC, adding new analytical chemistry and microbiology facilities that enhance efficiency, expand in-house testing capabilities, and support the company’s growing production capacity of 2.6 billion doses per year
Veranova Breaks Ground on ADC Facility Expansion
The $50M expansion of Veranova’s facility in Massachusetts adds 9,000 sf of state-of-the-art labs and cGMP suites to strengthen US pharmaceutical manufacturing, support advanced therapies like ADCs, and create up to 70 new jobs
Phased Expansion Shapes a cGMP-Ready Laboratory
Facing rapid demand for advanced analytical services in the US, Solvias successfully established a cGMP-ready Center of Excellence in North Carolina by using a phased expansion strategy and designing a flexible, digitally integrated lab to meet evolving market needs
Southwest Research Institute Expands Bioengineering Capacity with New Clinical Supply Facility
Southwest Research Institute has begun construction on a new 21,000-square-foot Clinical Supply Facility in San Antonio, TX, designed to centralize and expand its capabilities in pharmaceutical and bioengineering R&D, with advanced cleanroom environments supporting CGMP-compliant production of therapeutics, vaccines, and bioengineering products for clinical trials
Shaping a Sustainable Future for cGMP Facilities
The biopharmaceutical industry’s cGMP facilities are resource-intensive, but incorporating sustainable practices through holistic strategies—from process optimization to supply chain and MEP system improvements—can reduce their carbon footprint without compromising compliance, quality, or safety